- Home
- CTRM vs OSRH Comparison
CTRM vs OSRH Comparison
Compare CTRM & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CTRM | OSRH |
|---|---|---|
| Founded | 2016 | N/A |
| Country | Cyprus | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.2M | 18.4M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | CTRM | OSRH |
|---|---|---|
| Price | $2.20 | $0.50 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 55.1K | ★ 391.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.84 | $0.38 |
| 52 Week High | $2.67 | $4.33 |
Technical Indicators
Market Signals| Indicator | CTRM | OSRH |
|---|---|---|
| Relative Strength Index (RSI) | 51.61 | 51.70 |
| Support Level | $2.04 | $0.45 |
| Resistance Level | $2.43 | $0.76 |
| Average True Range (ATR) | 0.10 | 0.05 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 34.48 | 59.82 |
Price Performance
Historical ComparisonAbout CTRM Castor Maritime Inc.
Castor Maritime Inc is a provider of seaborne transportation services for dry bulk cargo, including iron ore, coal, grain, steel products, fertilizers, cement, bauxite, sugar, and scrap metal, among others. The firm operates under three reportable segments namely (i) the dry bulk segment (ii) the containership segment and (iii) the asset management segment. It generates maximum revenue from the Dry bulk segment.
About OSRH OSR Holdings Inc.
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.